CRESTLINE MANAGEMENT, LP Celldex Therapeutics, Inc. Transaction History

CRESTLINE MANAGEMENT, LP portfolio value:

$1.12M
portfolio value

CRESTLINE MANAGEMENT, LP quarter portfolio value change:

+4.27%
quarter

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +4.99% 1.9K shares 97K $28.11 39.99K
Q2 2022 share Increase +18.69% 5.99K shares -66K $26.96 38.09K
Q1 2022 share Increase 0.00% 32.09K shares 1.09M $34.06 32.09K